We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
06 Jun 2020 - 09 Jun 2020
Virtual Venue
08 Jun 2020 - 11 Jun 2020
Virtual Venue

Hand-Held Blood Analyzer Receives CE Mark

By LabMedica International staff writers
Posted on 15 Dec 2016
Print article
Image: The easy-to-use i-STAT Alinity handheld operates with the advanced technology of single-use i-STAT test cartridges (Photo courtesy of Abbott).
Image: The easy-to-use i-STAT Alinity handheld operates with the advanced technology of single-use i-STAT test cartridges (Photo courtesy of Abbott).
Globally, demand for healthcare is growing as people live longer, chronic diseases are more prevalent and people are more involved in decisions pertaining to their health. As more people access care, health systems, hospitals and other clinical care settings are challenged to keep pace and find resourceful, efficient and cost-effective ways to provide quality care.

In today's pressure-packed healthcare environment, clinicians rely on easy-to-use testing technologies that do not require complex training. Innovative point of care testing tools can help address this need and provide a simpler experience for those who use it, allowing them to accurately diagnose and treat patients faster and more efficiently.

An innovative, handheld blood-testing platform has received the CE Mark and is now for sale in Europe and other countries that recognize CE Mark. The portable device can perform and analyze the largest menu of blood tests on a single device, ranging from blood chemistries to cardiac markers, using only two to three drops of a person's blood. Delivering results in two to 10 minutes, the device equips healthcare professionals with the information they need to make fast and accurate medical decisions without ever leaving their patient's side. Its advanced connectivity features allow testing to be conducted virtually anywhere.

The i-STAT Alinity System (Abbott Point of Care Inc, Princeton, NJ, USA) returns results within two to 10 minutes and can run tests including blood chemistry and cardiac biomarkers. The system features expansive testing menu capabilities to enable the most combinations of tests in a single cartridge and new types of tests in the future, including tests for brain injury, infectious disease and oncology. Advanced quality control features designed with patient safety and regulatory compliance in the forefront; wireless or hard-wired connectivity so healthcare providers can manage diagnostic data and oversight with the broader healthcare system's network.

The system also features a large, bright, color touchscreen with graphics-driven, on-screen guidance and advanced light and sound notifications that alert clinicians with critical information. An ergonomic design with easy-grip handling that is balanced, comfortable and secure and durable materials designed to prevent damage from drops and harsh cleaning substances commonly used in clinical settings.

Matt Bates, PhD, divisional vice president of research and development at Abbott’s Point of Care Diagnostics division, said, “We spent countless hours doing on-the-ground research with doctors, nurses, lab directors, point of care coordinators and other customers from around the world. We asked about their pain points and listened to what they want and need for testing. Using these customer insights, Abbott designed and built i-STAT Alinity for better access, efficiency and speed to improve clinical decision making and positively impact patients' lives.”

Related Links:
Abbott Point of Care

Print article


Molecular Diagnostics

view channel
Image: Cartoon representation of the molecular structure of blaTEM (beta-lactamase) protein (Photo courtesy of Wikimedia Commons)

Changes in Bacterial Load and Serum Cytokine Levels Predict Likelihood of Dying from Sepsis

A testing method for the sensitive and rapid quantification of serum cytokines and bacterial load can be used to predict the likelihood of a patient dying from sepsis or septic shock. Sepsis is caused... Read more


view channel
Image: Stenotrophomonas maltophilia colonies on sheep blood agar. Cultivation 48 hours in an aerobic atmosphere, 37 °C (Photo courtesy of microbiologyinpictures).

Global Spread of the Multi-Resistant Pathogen Stenotrophomonas Maltophilia Revealed

Stenotrophomonas maltophilia strains occur in several natural and human associated ecosystems. The bacterium was long regarded as relatively unproblematic, but is now considered to be one of the most feared... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.